In this issue:
Frailty/comorbidity score improves stratification of MDS survival
International prognostic scoring system for mastocytosis
Single-agent in-trial ibrutinib vs. real-world treatments for CLL
Outcomes of allogeneic SCT for DLBCL
Somatic variants predict imatinib but not second-generation TKI failure
Diagnostic high-throughput sequencing in bleeding, thrombotic and platelet disorders
Hypertension and incident CV events following ibrutinib initiation
Characteristics and treatments for 10-year light-chain amyloidosis survivors
Thrombin-directed antibody vs. apixaban for preventing venous thrombosis
Please login below to download this issue (PDF)